UPR Uniphar plc

4.667USD4.255 EUR · ISE-0.70%Mkt Cap: 1.21B USDP/E: 20.26

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions…

Key Statistics

Company
Market Cap1.21B USD
Enterprise Value1.69B USD
Revenue (TTM)3.49B USD
Gross Profit502.00M USD
Net Income (TTM)56.03M USD
Revenue/Share13.44 USD
Last Price4.667 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.5K
CountryIE
SectorHealthcare
IndustryMedical Distribution
ISINIE00BJ5FQX74
Valuation
P/E (Trailing)20.26
P/E (Forward)15.18
PEG—
EV/EBITDA14.10
EV/Revenue0.48
P/S0.35
P/B2.59
EPS (TTM)0.23 USD
EPS (Forward)0.31 USD
52W Range
3.70755% of range5.457
52W High5.457 USD
52W Low3.707 USD
Profitability
Gross Margin14.89%
Oper. Margin2.95%
EBITDA Margin3.43%
Profit Margin1.66%
ROE12.61%
ROA2.95%
ROIC10.12%
ROCE10.19%
Growth
Revenue Growth7.20%
Earnings Growth16.70%
Cash Flow & Leverage
Operating CF118.93M USD
CapEx (TTM)68.90M USD
FCF Margin-1.42%
FCF Yield-4.09%
Net Debt474.83M USD
Net Debt/EBITDA3.97
Net Debt/FCF—
Balance Sheet
Debt/Equity1.27
Current Ratio0.97
Quick Ratio0.55
Book Value/Sh1.80 USD
Cash/Share0.37 USD
Dividends
Fwd Div Rate0.02 USD
Trail. Div Rate0.02 USD
Div. Yield0.48%
5Y Avg Yield0.57%
Payout Ratio9.81%
Ex-Div DateSep 17, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.108 USD
Upside (mean)+30.9%
Target Range5.484 USD – 7.349 USD
5.484+30.9% to mean7.349
# Analysts8
Ownership
Shares Out.259.57M
Float239.44M
Insiders5.52%
Institutions51.47%
Technical
SMA 504.459 (+4.7%)
SMA 2004.628 (+0.8%)
Beta1.16
S&P 52W Chg12.00%
Avg Vol (30d)270.76K
Avg Vol (10d)255.72K
Technical Indicators
RSI (14)55.2
MACD0.0753
MACD Signal0.0756
MACD Hist.-0.0003
BB Upper4.949 USD
BB Middle4.606 USD
BB Lower4.263 USD
BB Width14.90%
ATR (14)0.1084 USD
Vol Ratio (20d)0.43x

About Uniphar (ISE: UPR)

›

Uniphar (ISE: UPR) is listed on Euronext Dublin, where its shares trade in EUR. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 3,500 employees.

The shares were at 4.255 EUR on 19 November 2026, up 14.7% over 52 weeks. Its 52-week range is 3.380 EUR to 4.975 EUR: the price is 14.5% below the high and 25.9% above the low.

At a market capitalisation of 1.10B EUR, it trades at 20.3 times trailing earnings and 15.2 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 23.2, a discount of 13% for UPR. It pays a dividend yielding 0.48% (it pays out 10% of its earnings), against a median of 2.55% among the dividend payers in that peer group.

Uniphar reports return on equity of 12.6%, an operating margin of 2.9% and revenue up 7.2% year over year.

Its debt exceeds its cash by 432.93M EUR, a debt-to-equity ratio of 1.27. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 8 analysts cover the stock; their mean price target of 5.569 EUR is 30.9% above the current price.